Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats

Neuroscience Letters

Volumn 278, Issue 3, 2000, Pages 157-160

  Sinor, Amy D ^a   Irvin, Stacy M ^a   Greenberg, David A ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

2 Arachidonylglycerol; Anandamide; Cannabinoid; Cell culture; Hypoxia; Ischemia

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID; CANNABINOID CB1 RECEPTOR ANTAGONIST; CANNABINOID CB2 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR ANTAGONIST; DIZOCILPINE; GLUCOSE; METHANANDAMIDE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN CORTEX; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; HYPOXIA; ISCHEMIA; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARACHIDONIC ACIDS; BRAIN ISCHEMIA; CANNABINOIDS; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DIZOCILPINE MALEATE; ENDOCANNABINOIDS; EXCITATORY AMINO ACID ANTAGONISTS; GLYCERIDES; NEURONS; NEUROPROTECTIVE AGENTS; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033988703     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00922-2     Document Type: Article

References (16)

1. Abadji V., Lin S., Taha G., Griffin G., Stevenson L.A., Pertwee R.G., Makriyannis A. (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J. Med. Chem. 37:1994;1889-1893.
2. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 277:1997;1094-1097.
3. Chan G.C.-K., Hinds T.R., Impey S., Storm D.R. Hippocampal neurotoxicity of Δ9-tetrahydrocannabinol. J. Neurosci. 18:1998;5322-5332.
4. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
5. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.-C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
6. Di Marzo V., Melck D., Bisogno T., De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
7. Felder C.C., Veluz J.S., Williams H.L., Briley E.M., Matsuda L.A. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42:1992;838-845.
8. Hampson A.J., Grimaldi M., Axelrod J., Wink D. Cannabidiol and (-)Δ9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA. 95:1998;8268-8273.
9. Koretz B., Ahern K.v.B., Lustig H.S., Greenberg D.A. Pre- and postsynaptic modulators of excitatory neurotransmission: comparative effects on hypoxia/hypoglycemia in cortical cultures. Brain Res. 643:1994;334-337.
10. Mackie K., Devane W., Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44:1993;498-503.
11. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S., Jin K., Greenberg D.A. Cannabinoids and neuroprotection from global and focal cerebral ischemia and in vitro. J. Neurosci. 19:1999;2987-2995.
12. Shen M., Thayer S.A. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol. Pharmacol. 54:1998;459-462.
13. Skaper S.D., Buriani A., Dal Toso R., Petrelli L., Romanello S., Facci L., Leon A. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc. Natl. Acad. Sci. USA. 93:1996;3984-3989.
14. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
15. White M.J., DiCaprio M.J., Greenberg D.A. Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures. J. Neurosci. Methods. 70:1996;195-200.
16. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sørgård M., Di Marzo V., Julius D., Högestätt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.